1. Unveiling the therapeutic potential and nanotechnological approaches for the delivery of tanshinone IIA
   Diya Arora et al, 2024, Pharmacological Research - Modern Chinese Medicine CrossRef
2. The Glucose-Regulated Protein78 (GRP78) in the Unfolded Protein Response (UPR) Pathway: A Potential Therapeutic Target for Breast Cancer
   Mojgan Noroozi Karimabad et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
3. Tanshinone IIA ameliorates experimental diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress in cardiomyocytes via SIRT1
   Shun Wu et al, 2023, Phytotherapy Research CrossRef
4. Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
   Yanfang Zheng et al, 2022, Frontiers in Pharmacology CrossRef
5. Fufang Xueshuantong Improves Diabetic Cardiomyopathy by Regulating the Wnt/β-Catenin Pathway
   Meizhong Peng et al, 2022, International Journal of Endocrinology CrossRef
6. Signal transduction mechanism of exosomes in diabetic complications (Review)
   Xueting Li et al, 2021, Experimental and Therapeutic Medicine CrossRef
7. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies
   Andrii Puzyrenko et al, 2021, Cell Stress and Chaperones CrossRef
8. Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
   Lianjun Ao et al, 2023, Frontiers in Pharmacology CrossRef
9. Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
   Namrita Kaur et al, 2020, Frontiers in Cardiovascular Medicine CrossRef
10. The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
    Li Fu et al, 2020, Frontiers in Pharmacology CrossRef